investing-statsSEC Form 4 insider transactions

OKUR · OnKure Therapeutics, Inc.

← all insiders

Pharmaceutical Preparations · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades2
Distinct insiders2
Bought$0
Sold$1.7K
Net flow$-1.7K

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for OKUR
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-11Carruthers R MichaelDirectorA buy22,350 22,350 Class A Common Stock22,350filing
2026-08-11Phillips Andrew JohnDirectorA buy22,350 22,350 Class A Common Stock22,350filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)A buy542,232 542,232 Class A Common Stock542,232filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)D sell542,232 542,232 Class A Common Stock0filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)A buy16,898 16,898 Class A Common Stock16,898filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)D sell16,898 16,898 Class A Common Stock0filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)A buy8,449 8,449 Class A Common Stock8,449filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)D sell8,449 8,449 Class A Common Stock0filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)A buy1,485 1,485 Class A Common Stock1,485filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)D sell1,485 1,485 Class A Common Stock0filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)A buy2,359 2,359 Class A Common Stock2,359filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)D sell2,359 2,359 Class A Common Stock0filing
2026-08-11Saccomano Nicholas ADirector, Officer (President and CEO)A buy150,000 150,000 Class A Common Stock150,000filing
2026-08-11Ratcliffe LiamDirectorA buy22,350 22,350 Class A Common Stock22,350filing
2026-08-11Mathers Edward TDirectorA buy22,350 22,350 Class A Common Stock22,350filing
2026-08-11Manke IsaacDirectorA buy15,300 15,300 Class A Common Stock15,300filing
2026-08-11Manke IsaacDirectorD sell15,300 15,300 Class A Common Stock0filing
2026-08-11Manke IsaacDirectorA buy300,000 300,000 Class A Common Stock300,000filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)A buy130,611 130,611 Class A Common Stock130,611filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)D sell130,611 130,611 Class A Common Stock0filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)A buy5,322 5,322 Class A Common Stock5,322filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)D sell5,322 5,322 Class A Common Stock0filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)A buy5,781 5,781 Class A Common Stock5,781filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)D sell5,781 5,781 Class A Common Stock0filing
2026-08-11Leverone Jason A.Officer (Chief Financial Officer)A buy50,000 50,000 Class A Common Stock50,000filing
2026-08-11Jansen Valerie MalyvanhDirectorA buy22,350 22,350 Class A Common Stock22,350filing
2026-08-11Hartley DylanOfficer (Chief Scientific Officer)A buy137,603 137,603 Class A Common Stock137,603filing
2026-08-11Hartley DylanOfficer (Chief Scientific Officer)D sell137,603 137,603 Class A Common Stock0filing
2026-08-11Hartley DylanOfficer (Chief Scientific Officer)A buy50,000 50,000 Class A Common Stock50,000filing
2026-08-11GREY MICHAEL GDirectorA buy22,350 22,350 Class A Common Stock22,350filing
2026-08-11Agresta SamuelOfficer (Chief Medical Officer)A buy131,396 131,396 Class A Common Stock131,396filing
2026-08-11Agresta SamuelOfficer (Chief Medical Officer)D sell131,396 131,396 Class A Common Stock0filing
2026-08-11Agresta SamuelOfficer (Chief Medical Officer)A buy18,588 18,588 Class A Common Stock18,588filing
2026-08-11Agresta SamuelOfficer (Chief Medical Officer)D sell18,588 18,588 Class A Common Stock0filing
2026-08-11Agresta SamuelOfficer (Chief Medical Officer)A buy50,000 50,000 Class A Common Stock50,000filing
2026-06-24Saccomano Nicholas ADirector, Officer (President and CEO)S sell860$4.40$37811,247−0.8%−<0.01% (now 0.03%)filing
2026-06-24Leverone Jason A.Officer (Chief Financial Officer)S sell3030$4.40$1.3K18,802−2%−<0.01% (now 0.05%)filing
2026-06-08Phillips Andrew JohnDirectorA buy7,650 7,650 Class A Common Stock7,650filing
2026-06-08Ratcliffe LiamDirectorA buy1,275 1,275 Class A Common Stock1,275filing
2026-06-08Mathers Edward TDirectorA buy7,650 7,650 Class A Common Stock7,650filing
2026-06-08Jansen Valerie MalyvanhDirectorA buy7,650 7,650 Class A Common Stock7,650filing
2026-06-08GREY MICHAEL GDirectorA buy7,650 7,650 Class A Common Stock7,650filing
2026-06-08Carruthers R MichaelDirectorA buy7,650 7,650 Class A Common Stock7,650filing
2026-04-03Saccomano Nicholas ADirector, Officer (President and CEO)A buy330,000 330,000 Class A Common Stock330,000filing
2026-04-03Leverone Jason A.Officer (Chief Financial Officer)A buy110,000 110,000 Class A Common Stock110,000filing
2026-04-03Hartley DylanOfficer (Chief Scientific Officer)A buy110,000 110,000 Class A Common Stock110,000filing
2026-04-03Agresta SamuelOfficer (Chief Medical Officer)A buy110,000 110,000 Class A Common Stock110,000filing
2026-04-01Ratcliffe LiamDirectorA buy15,300 15,300 Class A Common Stock15,300filing
2026-03-24Saccomano Nicholas ADirector, Officer (President and CEO)S sell860$4.16$3577,333−1%−<0.01% (now 0.02%)filing
2026-03-24Leverone Jason A.Officer (Chief Financial Officer)S sell3010$4.16$1.3K16,000−2%−<0.01% (now 0.04%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.